1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,440 | 3,580 | 14:32 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | Amplitude Surgical Announces H1 2024-25 Results: 51.5 M€ Sales and 13.1 M€ EBITDA | 223 | Business Wire | Consolidated sales of €51.5m, up 6.3% at constant exchange rates
EBITDA up 10.6% to €13.1 million, EBITDA margin 25.4%
Current operating income of €6.0 million
Cash position... ► Artikel lesen | |
| 12.03. | XFRA 1AU: WIEDERAUFNAHME/RESUMPTION | 139 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 11.03. | XFRA 1AU: AUSSETZUNG/SUSPENSION | 178 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAMPLITUDE SURGIC.... ► Artikel lesen | |
| 11.03. | Zydus Life inks pact to acquire majority stake in Amplitude Surgical | 2 | capitalmarket.com | ||
| 11.03. | Zydus Enters Exclusive Negotiations with PAI Partners and Other Shareholders to Acquire a Majority stake in Amplitude Surgical, France | 259 | Business Wire | Completion of the transaction to be followed by mandatory simplified tender offer
Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical,... ► Artikel lesen | |
| 20.02. | Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of €51.5m, +6.3% at Constant Exchange Rates | 247 | Business Wire | Consolidated sales of €51.5 million, up+ 6.3% at constant exchange rates
Good sales growth in France at +4.6%
Strong growth in international business thanks to subsidiaries, with... ► Artikel lesen | |
| AMPLITUDE SURGICAL Aktie jetzt für 0€ handeln | |||||
| 21.11.24 | Amplitude Surgical - First Quarter 2024-25: Consolidated Sales of €21.8m, +7.5% at Constant Exchange Rates | 547 | Business Wire | VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics... ► Artikel lesen | |
| 20.11.24 | Amplitude Surgical Announces Its 2024-25 Financial Calendar | 90 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda... ► Artikel lesen | |
| 23.10.24 | Amplitude Surgical - Fiscal Year 2023-24: 106.0 M€ Sales and €27.1m EBITDA | 442 | Business Wire | Consolidated sales of €106.0 million, up 6.3% at constant exchange rates
EBITDA up to €27.1m (+3.7%), EBITDA rate at 25.6%.
Current operating income of €12.7 million
Cash... ► Artikel lesen | |
| 25.07.24 | Amplitude Surgical - Consolidated Annual Sales of €106.0m, up +6.3% at Constant Exchange Rates | 258 | Business Wire | Growth of 7.0% at constant exchange rates in the fourth quarter of FY 2023-2024 and 6.3% for the full year
5.0% sales growth in France
Good momentum outside France, with sales up... ► Artikel lesen | |
| 18.04.24 | Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates | 251 | Business Wire | VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 2,792 | -3,19 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| PING AN HEALTHCARE | 0,848 | -1,67 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| ORGANON | 13,055 | -3,80 % | Organon & Co.: Europäische Arzneimittelagentur (EMA) validiert Antrag von Henlius und Organon für Perjeta (Pertuzumab) Biosimilar-Kandidat HLX11 | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Arzneimittelagentur (EMA) den Antrag auf Marktzulassung (MAA) für HLX11, ein in der Entwicklung... ► Artikel lesen | |
| EMEIS | 10,000 | -2,69 % | New Partnership Between NLV and emeis for Affordable Care Facilities in the Netherlands | Regulatory News:
emeis (Paris:EMEIS) and the real estate asset manager NLV have signed a partnership, to support the expansion of emeis Group in the Netherlands, and marking NLV's first investment... ► Artikel lesen | |
| CYTOSORBENTS | 0,914 | -1,40 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights | 2024 marked by strong commercial execution and improved operating leverage
Company continues to expect DrugSorb-ATR regulatory decisions from Health Canada and... ► Artikel lesen | |
| CLARIANE | 3,868 | -2,13 % | Clariane: Information on the Availability of the 2024 Universal Registration Document | Regulatory News:
Clariane (CLARI.PA ISIN: FR0010386334) announces the release of its 2024 Universal Registration Document.
The 2024 Universal Registration Document was filed with the French... ► Artikel lesen | |
| ARJO | 3,312 | -3,83 % | Arjo AB Aktie: Umsatzplus im überblickbaren Bereich! | Der schwedische Medizintechnikkonzern meldet Umsatzsteigerung trotz volatiler Börsenperformance und erhält wichtige FDA-Zulassung für neue Diagnostiktechnologie. Arjo AB hat für Dienstag, den 29. April... ► Artikel lesen | |
| M3 INC | 10,500 | +2,94 % | Investoren meiden heute das Wertpapier von M3: Kurs gibt deutlich nach (10,25 €) | Die Aktie von M3 zählt am Dienstag zu den großen Verlierern am Aktienmarkt. Der Kurs des Anteilsscheins sackt kräftig ab. Kein guter Tag bislang für Inhaber von M3: Das Wertpapier weist zur Stunde einen... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 0,745 | 0,00 % | INTERPACE BIOSCIENCES, INC. - 10-K, Annual Report | ||
| NYXOAH | 5,500 | -8,94 % | Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks | ||
| DYNAVOX GROUP | 5,680 | -2,91 % | Dynavox Group publishes Annual Report 2024 | ||
| VIVANI MEDICAL | 0,810 | -8,47 % | Vivani Medical, Inc.: Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results | Successful initial administration and full enrollment in first-in-human LIBERATE-1 study of NPM-115 (exenatide implant) in obese and overweight subjects with top-line data expected in mid-2025 Positive... ► Artikel lesen | |
| CHINA MEDICAL SYSTEM | 0,960 | +1,59 % | CMS (00867): FORM OF PROXY | ||
| NANOSONICS | 2,720 | -0,73 % | NANOSONICS LIMITED: Notification of cessation of securities - NAN | ||
| MICROPORT SCIENTIFIC | 0,915 | -6,15 % | M Stanley Narrowly Lifts MICROPORT TP to $8.6, Rating Equal-weight |
AMPLITUDE SURGICAL gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -2,52 % bei einem Aktienkurs von 5,800 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AMPLITUDE SURGICAL finden Sie auf Wallstreet Online.
